Sanders Morris Harris LLC Global Blood Therapeutics, Inc. Transaction History

Sanders Morris Harris LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 11, 2022	SELL	$22.3 - $37.39 $144,950 - $243,035	-6,500 Reduced 50.0%	6,500 $213,000
Q1 2022 Apr 11, 2022	BUY	$25.68 - $35.59 $333,840 - $462,670	13,000 New	13,000 $450,000
Q3 2021 Oct 13, 2021	SELL	$25.48 - $37.34 $171,990 - $252,045	-6,750 Closed	0 $0
Q1 2021 Apr 19, 2021	BUY	$38.94 - $50.85 $9,735 - $12,712	250 Added 3.85%	6,750 $285,000
Q1 2021 Apr 14, 2021	SELL	$38.94 - $50.85 $9,735 - $12,712	-250 Reduced 3.7%	6,500 $275,000
Q3 2020 Oct 16, 2020	BUY	$52.76 - $74.49 $356,130 - $502,807	6,750 New	6,750 $408,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Sanders Morris Harris LLC, based on Form 13F filings with the SEC.

Stay updated on Sanders Morris Harris LLC with notifications on news.